Stimulatory effect of nitric oxide on bicarbonate secretion in bullfrog duodenums in vitro

被引:24
作者
Furukawa, O [1 ]
Kitamura, M [1 ]
Sugamoto, S [1 ]
Takeuchi, K [1 ]
机构
[1] Kyoto Pharmaceut Univ, Dept Pharmacol & Expt Therapeut, Kyoto 6078414, Japan
关键词
HCO3-; secretion; bullfrog duodenum; nitric oxide donor; cGMP; cAMP; prostaglandin; in vitro;
D O I
10.1159/000007678
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The effect of nitric oxide (NO) on HCO3- secretion was examined in vitro using an isolated preparation of bullfrog duodenum. The tissue was bathed in unbuffered Ringer's solution gassed with 100% O-2 on the mucosal side and HCO3- Ringer's solution gassed with 95% O-2-5% CO2 on the serosal side. The HCO3- secretion was measured by the pH-stat method using 2 mmol/l HCl as the titrant to keep the mucosal pH at 7.4. (+/-)-(E)-Ethyl-2-[(E)-hydroxyimino]-5-nitro-3-hexenamine (NOR3) was used as a NO donor and added to the serosal solution. To analyze the NOR3 action on HCO3- secretion, the effects of dibutyryl adenosine-3',5'-cyclic monophosphate (dbcAMP), dibutyryl guanosine-3',5'-cyclic monophosphate (dbcGMP), methylene blue, and indomethacin on the HCO, response were also examined. NOR3 (1 x 10(-4) and 3 x 10(-4) mol/l) caused an increase in HCO3- secretion in a dose-dependent manner, and this effect appeared with an about 30-min time lag, reaching the level of 1.5-2.5 times greater than basal values at 1-2 h later. Both dbcAMP (1 x 10(-3) mol/l) and dbcGMP (1 x 10(-3) mol/l) also caused a significant increase in HCO3- secretion in bullfrog duodenums in vitro, although the onset of the HCO3- response to dbcGMP was delayed as compared to the former. The stimulatory action of NOR3 on duodenal HCO3- secretion was significantly attenuated by methylene blue (5 x 10(-5) mol/l) and indomethacin (1 x 10(-5) mol/l), the latter also inhibiting the HCO3- response to dbcGMP. The release of prostaglandin E-2 in the serosal solution was significantly increased after addition of NOR3 (3 x 10(-4) mol/l) and dbcGMP (1 x 10(-3) mol/l) in an indomethacin-sensitive manner. These results suggest that the NO donor increases duodenal HCO3- secretion in vitro, and this action of NO donor is cGMP-dependent and mediated by endogenous prostaglandins. Duodenal HCO3- secretion may be regulated locally by NO/cGMP in addition to prostaglandin/cAMP.
引用
收藏
页码:324 / 331
页数:8
相关论文
共 30 条
[1]  
Bilski J, 1994, J Physiol Pharmacol, V45, P541
[2]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[3]   Water extract of Helicobacter pylori inhibits duodenal mucosal alkaline secretion in anesthetized rats [J].
Fandriks, L ;
VonBothmer, C ;
Johansson, B ;
Holm, M ;
Bolin, I ;
Pettersson, A .
GASTROENTEROLOGY, 1997, 113 (05) :1570-1575
[4]   STIMULATION OF HCO3 TRANSPORT IN ISOLATED PROXIMAL BULLFROG DUODENUM BY PROSTAGLANDINS [J].
FLEMSTROM, G .
AMERICAN JOURNAL OF PHYSIOLOGY, 1980, 239 (03) :G198-G203
[5]  
FLEMSTROM G, 1982, AM J PHYSIOL, V242, P183
[6]   SELECTIVE-INHIBITION OF NS-398 ON PROSTANOID PRODUCTION IN INFLAMED TISSUE IN RAT CARRAGEENAN-AIR-POUCH INFLAMMATION [J].
FUTAKI, N ;
ARAI, I ;
HAMASAKA, Y ;
TAKAHASHI, S ;
HIGUCHI, S ;
OTOMO, S .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1993, 45 (08) :753-755
[7]   Guanylin strongly stimulates rat duodenal HCO3- secretion: Proposed mechanism and comparison with other secretagogues [J].
Guba, M ;
Kuhn, M ;
Forssmann, WG ;
Classen, M ;
Gregor, M ;
Seidler, U .
GASTROENTEROLOGY, 1996, 111 (06) :1558-1568
[8]   EFFECTS OF NITRIC-OXIDE INHIBITION ON DUODENAL FUNCTION IN RAT - INVOLVEMENT OF NEURAL MECHANISMS [J].
HALLGREN, A ;
FLEMSTROM, G ;
SABABI, M ;
NYLANDER, O .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 1995, 269 (02) :G246-G254
[9]   REGULATION OF GASTRODUODENAL HCO3- TRANSPORT BY LUMINAL ACID IN THE FROG INVITRO [J].
HEYLINGS, JR ;
GARNER, A ;
FLEMSTROM, G .
AMERICAN JOURNAL OF PHYSIOLOGY, 1984, 246 (03) :G235-G242
[10]   Cyclo-oxygenase isozymes in mucosal ulcerogenic and functional responses following barrier disruption in rat stomachs [J].
Hirata, T ;
Ukawa, H ;
Yamakuni, H ;
Kato, S ;
Takeuchi, K .
BRITISH JOURNAL OF PHARMACOLOGY, 1997, 122 (03) :447-454